Direct-acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study.
A W SingerRajender K ReddyL E TelepA O OsinusiD M BrainardM ButiAnand P ChokkalingamPublished in: Alimentary pharmacology & therapeutics (2018)
In this large, population-based study, DAA-based treatment was associated with a reduced risk of incident liver cancer relative to both no HCV treatment and to interferon-based treatment in the pre-DAA era. As additional follow-up time of DAA-treated patients accrues, we anticipate that the long-term benefits of DAA treatment will become more apparent.